Three different treatments for wet age-related macular degeneration – Eylea
Eylea is licensed and FDA approved like Lucentis for eye use (unlike Avastin) and is one of the two approved treatments for Wet Age-related Macular Degeneration.
Eylea is licensed and FDA approved like Lucentis for eye use (unlike Avastin) and is one of the two approved treatments for Wet Age-related Macular Degeneration.
It's fair to say that Lucentis is the most researched medicine for wet age related macular degeneration to date and has been the leading treatment for some time.
Is Avastin as effective as Lucentis in the treatment of wet age related macular degeneration? The CATT study was conducted to answer this very question. The answer is probably yes.